Teacher Retirement System of Texas raised its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 134.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,225 shares of the company's stock after acquiring an additional 25,909 shares during the quarter. Teacher Retirement System of Texas' holdings in AdaptHealth were worth $431,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Barclays PLC grew its stake in AdaptHealth by 361.3% during the third quarter. Barclays PLC now owns 181,240 shares of the company's stock worth $2,034,000 after purchasing an additional 141,949 shares during the period. Principal Financial Group Inc. increased its stake in shares of AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company's stock valued at $6,106,000 after acquiring an additional 154,434 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of AdaptHealth by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company's stock valued at $2,154,000 after acquiring an additional 81,097 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in AdaptHealth by 7.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 162,470 shares of the company's stock worth $1,825,000 after purchasing an additional 11,757 shares during the period. Finally, Reinhart Partners LLC. increased its stake in AdaptHealth by 1.1% in the fourth quarter. Reinhart Partners LLC. now owns 6,266,854 shares of the company's stock valued at $59,660,000 after purchasing an additional 68,212 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
AHCO has been the subject of a number of research analyst reports. Robert W. Baird boosted their target price on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Truist Financial upped their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada lifted their price target on shares of AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Canaccord Genuity Group upped their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Finally, UBS Group reduced their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a report on Thursday, February 13th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $13.80.
Read Our Latest Stock Report on AHCO
AdaptHealth Stock Down 2.2 %
Shares of NASDAQ AHCO traded down $0.23 during trading on Friday, hitting $10.10. The stock had a trading volume of 1,319,642 shares, compared to its average volume of 1,197,433. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a fifty day moving average of $10.04 and a two-hundred day moving average of $10.15. AdaptHealth Corp. has a 12 month low of $8.35 and a 12 month high of $11.90. The company has a market capitalization of $1.36 billion, a PE ratio of -6.12, a PEG ratio of 1.08 and a beta of 1.44.
AdaptHealth Profile
(
Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Further Reading
Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
